CompoAtlas

NOW Air Defence with Paractin Vcaps

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Olea europea

Source : Feuille

Extraction ratio : 4:1

Dry plant equivalent : 134 mg

Potency : 6 % Oleoeuropein

33.5 mgNot calculated
Echinacea angustifolia

Source : Racine

33.5 mgNot calculated
Vitamine C

Source : Acide ascorbique

250 mg1,500,000 µg
Vitamine C

Source : Vitamine C

250 mg1,500,000 µg
Magnésium

Source : Oxyde de magnésium

22.5 mg135,000 µg
Sambucus nigra

Source : Fruit

Extraction ratio : 10:1

Dry plant equivalent : 335 mg

33.5 mgNot calculated
L-lysine

Source : Monochlorhydrate de L-lysine

12.5 mgNot calculated
Bêta-carotène

Source : Bêta carotène

Potency : 500 mcg Pro Vitamin A

125 mcg EARNot calculated
Bêta-carotène

Source : Bêta-carotène tout trans

Potency : 500 mcg Pro Vitamin A

125 mcg EARNot calculated
Sélénium

Source : Sélénométhionine

25 mcg150 µg
Andrographis paniculata

Source : Parties aériennes

5 mgNot calculated
Zingiber officinale

Source : Racine

Extraction ratio : 10:1

Dry plant equivalent : 85 mg

Not specifiedNot calculated

Non-medicinal ingredients

Stéarate de magnésium, cellulose, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to maintain immune function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Product record

Licence holder
NOW Health Group, Inc.
NPN or DIN-HM
80035419
Status
Active licence
Licence date
14 September 2012
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80035419

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Echinacea angustifolia
    Read the warning, when it applies and the studies cited

    ECHINACEA- ECHINACEA ANGUSTIFOLIA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (Gardner and McGuffin 2013; Brinker 2010).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 28 March 2025

  • Sambucus nigra
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    Sources cited by Health Canada (1)
    • Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
    • Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Zingiber officinale
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “NOW Air Defence with Paractin Vcaps (NOW Health Group, Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80035419-now-air-defence-with-paractin-vcaps, updated 14 September 2012.

Enter to analyse, Shift+Enter for a new line